Rembrandt Diagnostics LP v. Alere, Inc. (Fed. Cir. 2023) | McDonnell Boehnen Hulbert & Berghoff LLP

The Federal Circuit reviewed the latest decision from the Patent Trial and Appeal Board (PTAB) in an inter partes review that claims 3-6 and 10 of U.S. Patent No. 6,548,019 are obvious,...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Biomarin Pharm ,Anacor Pharms Inc ,Illumina Cambridge Ltd ,Ericsson ,Henny Penny Corp ,Verinata Health Inc ,World Techs Inc ,Alere Inc ,Belden Inc ,Ericsson Inc ,Psys Inc ,Chamberlain Grp Inc ,Institute Inc ,Federal Circuit ,Patent Trial ,Appeal Board ,Rembrandt Diagnostics ,Final Written Decision ,Judge Reyna ,Chief Judge Moore ,Intelligent Bio Sys ,Cambridge Ltd ,Henny Penny ,Chamberlain Grp ,World Techs ,Anacor Pharms ,Genzyme Therapeutic ,Patent Owner ,Ariosa Diagnostics ,What Rembrandt ,Circuit Judges Dyk ,Circuit Judge ,